Compare · CHD vs WALD
CHD vs WALD
Side-by-side comparison of Church & Dwight Company Inc. (CHD) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHD and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- CHD is the larger of the two at $24.33B, about 139.1x WALD ($174.9M).
- CHD has been more active in the news (10 items in the past 4 weeks vs 4 for WALD).
- CHD has more recent analyst coverage (25 ratings vs 11 for WALD).
- Company
- Church & Dwight Company Inc.
- Waldencast plc
- Price
- $102.53+0.03%
- $1.37+1.48%
- Market cap
- $24.33B
- $174.9M
- 1M return
- -
- -19.88%
- 1Y return
- -
- -13.56%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 10
- 4
- Recent ratings
- 25
- 11
Church & Dwight Company Inc.
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products in the United States and internationally. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; and cold remedy products under the ZICAM brand. It also provides specialty products, including animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast based prebiotic. In addition, the company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest CHD
- EVP Chief Tech&Global New Prod Linares Carlos G. exercised 15,375 shares at a strike of $50.28 and sold $1,568,250 worth of shares (15,375 units at $102.00) (SEC Form 4)
- Church & Dwight to Present at the 2026 Barclays Global Consumer Staples Conference
- SEC Form 4 filed by EVP Chief Tech&Global New Prod Linares Carlos G.
- SEC Form 4 filed by President and CEO Dierker Richard A
- SEC Form 4 filed by EVP of Strategy, M&A, and BP Buchert Brian D
- Director Irwin Bradley C exercised 4,300 shares at a strike of $77.33 and sold $441,575 worth of shares (4,300 units at $102.69) (SEC Form 4)
- Director Winkleblack Arthur B exercised 13,200 shares at a strike of $50.28 and sold $1,357,310 worth of shares (13,200 units at $102.83) (SEC Form 4)
- SEC Form 4 filed by EVP Chief Tech&Global New Prod Linares Carlos G.
- SEC Form 4 filed by President and CEO Dierker Richard A
- SEC Form 4 filed by EVP of Strategy, M&A, and BP Buchert Brian D
Latest WALD
- SEC Form 4 filed by Chief Executive Officer Brousset Michel
- SEC Form 4 filed by Chief Growth Officer Sebti Hind
- Chief Financial Officer Manfredi Manuel converted options into 79,289 units of Class A Ordinary Shares, increasing direct ownership by 200% to 118,933 units (SEC Form 4)
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
- SEC Form 6-K filed by Waldencast plc
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel